Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zhenyuan capsule for heart failure after myocardial infarction
ChiCTR2200057496Phase 4Not yet recruiting
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of Zhenyuan Capsule in heart failure (HF) and myocardial infarction (MI) (2 arms), sponsored by Zhongshan Hospital, Fudan University. Primary endpoint: Improvement in quality of life. Planned start Apr 2021; status: not yet recruiting.
02
Drugs
Zhenyuan Capsule
03
Conditions
heart failure (HF)myocardial infarction (MI)
Beyond the preview
Go deeper on ChiCTR2200057496.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200057496.